Legacy Wealth Asset Management LLC Sells 112 Shares of Chemed Co. (NYSE:CHE)

Legacy Wealth Asset Management LLC decreased its position in shares of Chemed Co. (NYSE:CHE) by 4.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,446 shares of the company’s stock after selling 112 shares during the period. Legacy Wealth Asset Management LLC’s holdings in Chemed were worth $1,296,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. American National Bank & Trust purchased a new stake in shares of Chemed in the third quarter worth $61,000. GAMMA Investing LLC lifted its stake in shares of Chemed by 60.5% during the 3rd quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock valued at $83,000 after buying an additional 52 shares in the last quarter. Quarry LP boosted its holdings in Chemed by 721.7% in the 2nd quarter. Quarry LP now owns 189 shares of the company’s stock worth $103,000 after buying an additional 166 shares during the period. Sound Income Strategies LLC purchased a new stake in Chemed in the 3rd quarter worth $201,000. Finally, Farther Finance Advisors LLC raised its holdings in Chemed by 2,314.3% during the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock valued at $203,000 after acquiring an additional 324 shares during the period. Institutional investors own 95.85% of the company’s stock.

Insider Activity at Chemed

In related news, EVP Spencer S. Lee sold 732 shares of the stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the completion of the transaction, the executive vice president now owns 18,287 shares of the company’s stock, valued at approximately $10,526,362.94. This trade represents a 3.85 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the completion of the transaction, the chief executive officer now owns 101,735 shares of the company’s stock, valued at approximately $58,270,755.95. This represents a 1.93 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

CHE has been the subject of several research analyst reports. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th. Royal Bank of Canada dropped their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th.

Chemed Stock Performance

Shares of NYSE CHE opened at $555.46 on Friday. The firm’s fifty day moving average is $545.40 and its two-hundred day moving average is $562.40. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62. The company has a market cap of $8.36 billion, a P/E ratio of 28.07, a P/E/G ratio of 2.04 and a beta of 0.47.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, October 29th. The company reported $5.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.76 by ($0.12). Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm had revenue of $606.18 million during the quarter, compared to the consensus estimate of $612.22 million. During the same period last year, the firm posted $5.32 earnings per share. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. As a group, analysts forecast that Chemed Co. will post 21.43 EPS for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Monday, November 18th were given a dividend of $0.50 per share. The ex-dividend date was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. Chemed’s dividend payout ratio is currently 10.11%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.